US approves new HIV treatment
May 21st, 2011 - 11:52 am ICT by IANSWashington, May 21 (IANS/EFE) The US Food and Drug Administration approved Friday a new treatment for AIDS which, used with other antiretroviral medications, blocks the reproduction of the HIV virus that causes the disease.
Developed by Johnson & Johnson, TMC278, also known as rilpivirine, is especially for patients who have never begun HIV treatment, the FDA said in a statement.
J&J; will market the drug under the name Edurant.
The new medication was approved after two clinical trials were carried out with 1,368 adults who had received no previous anti-HIV treatment.
During the trials, the patients were randomly assigned treatments with rilpivirine or efavirenz (sold by Bristol-Myers Squibb Co. as Sustiva), and with other pharmaceuticals.
In the clinical trials, 83 percent of those who received rilpivirine suppressed the reproduction of the virus at undetectable levels, while the same occurred with 80 percent of those who received efavirenz.
The most common side effects among patients who took Edurant included depression, insomnia, headaches and rashes.
The FDA warned that Edurant does not cure HIV infections and that patients must have continuous treatment with the new once-a-day pill to control infection and reduce the tendency to contract illnesses caused by the virus.
–IANS/EFE
rd
- First ever pill to beat HIV under FDA consideration - May 10, 2012
- HIV vaccine being tested in Spain - Sep 29, 2011
- Human trials under way for new HIV vaccine - Jan 03, 2012
- FDA-approved drugs that may fight HIV identified - Aug 21, 2010
- New drug busts clot risks in joint replacement - Sep 19, 2011
- No gender-based difference in HIV treatment response - Sep 21, 2010
- Russia tests HIV vaccine - Feb 06, 2012
- How HIV reactivates after entering a dormant state - Feb 27, 2011
- Promising new HIV drug keeps virus out of cells - Aug 19, 2010
- How 'silent HIV virus' attacks immune system - Sep 21, 2010
- Ranbaxy approved to make first generic version of Lipitor - Dec 01, 2011
- New antibiotic recommended for treating typhoid in low-income countries - Apr 29, 2011
- Scientists tame HIV by stripping it of cholesterol - Sep 29, 2011
- Bristol Myers Get Approval For Their Diabetes Drug - Nov 07, 2010
- Brain can act as a haven for HIV virus: Study - Aug 24, 2010
Tags: bristol myers, bristol myers squibb, bristol myers squibb co, clinical trials, continuous treatment, efavirenz, food and drug, food and drug administration, headaches, hiv, hiv infections, hiv treatment, hiv virus, illnesses, insomnia, johnson johnson, pharmaceuticals, sustiva, undetectable levels, us food and drug administration